SynthesisJournal of medical imaging and radiation oncology2026
Non-Contrast MRI for Hepatocellular Carcinoma Surveillance and Diagnosis: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.
Synthesis in Journal of medical imaging and radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide, particularly among patients with chronic liver disease and cirrhosis. Non-contrast magnetic resonance imaging (NC-MRI) has emerged as a potential alternative imaging modality for HCC surveillance and diagnosis, avoiding the risks associated with contrast agents; however, its diagnostic performance has not been fully established. This systematic review and meta-analysis aimed to evaluate the diagnostic accuracy of NC-MRI for the detection and surveillance of HCC.
methodsA comprehensive systematic search of five electronic databases (PubMed, EMBASE, Scopus, the Cochrane Library, and Web of Science) was conducted. Eligible studies evaluated NC-MRI for HCC diagnosis or surveillance and reported sufficient data to construct diagnostic accuracy measures. Data were extracted on study characteristics, patient populations, NC-MRI protocols, reference standards, and diagnostic outcomes, including sensitivity, specificity, diagnostic odds ratio (DOR), and likelihood ratios. Subgroup analyses were performed according to study design, reference standard, and imaging intent (diagnostic vs. surveillance).
resultsTwenty-one studies comprising 7412 participants were included. The pooled sensitivity and specificity of NC-MRI for HCC detection were 84% and 94%, respectively. The pooled DOR was 78 (95% CI: 50-122), with a positive likelihood ratio (LR+) of 13 (95% CI: 9-19) and a negative likelihood ratio (LR-) of 0.17 (95% CI: 0.13-0.22). Subgroup analyses demonstrated higher diagnostic performance in prospective studies and when NC-MRI was applied for surveillance purposes. Studies using histopathology as the reference standard also showed high diagnostic accuracy, with a DOR of 74.
conclusionNC-MRI demonstrates consistently high diagnostic accuracy across diverse study settings and represents a promising contrast-free imaging option in selected high-risk populations. However, its role in population-based surveillance requires cautious interpretation, particularly for early-stage disease and warrants further prospective validation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.